Mithril
QuietSan Francisco, CABiotechnology, Healthcare, PharmaceuticalsLast fund filed April 2016
1 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| MITHRIL II | April 2016 | $740M | $740M | 0 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
1 partner is named across this firm’s filings, 1 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Ajay Royan | Quiet | Biotech & pharma, Aerospace & defense, Fintech | 14 | 0 |
Classified sectors of Mithril’s own portfolio companies, based on 9 with a verified or cited source.
| Firm | Shared boards | Companies |
|---|---|---|
| Borealis | 2 | Ankyra Therapeutics, Avitide |
| Polaris Partners | 2 | Adagio Therapeutics, Ankyra Therapeutics |
| 82vs | 1 | Avitide |
| Bessemer Venture Partners | 1 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Mithril’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| DOUBLEDUTCH |
| Bullpen Capital | 1 | DOUBLEDUTCH |
| GTP AW | 1 | Avitide |
| Lux Capital | 1 | AURIS SURGICAL ROBOTICS |
| Mayfield | 1 | NuVia |
| RRE Ventures | 1 | Spaceflight Industries |
| SV Life Sciences | 1 | Avitide |
| Union Square Ventures | 1 | Pollen |
| Virtuoso-mccarran | 1 | Avitide |
| Wrvi Capital | 1 | NuVia |
A shared board seat: a company where filings name a Mithril partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.